Valuation : Bio-Rad Laboratories, Inc.

Market Cap 10.27B 8.84B 8.29B 7.59B 14.16B 971B 14.27B 98.09B 38.2B 496B 38.56B 37.72B 1,598B P/E 2026 *
46.6x
P/E 2027 * 45.7x
Enterprise Value 9.52B 8.19B 7.69B 7.03B 13.13B 900B 13.23B 90.93B 35.41B 460B 35.75B 34.97B 1,481B EV / Sales 2026 *
3.7x
EV / Sales 2027 * 3.53x
Free-Float
60.2%
Yield 2026 *
-
Yield 2027 * -
1 day-0.27%
1 week-0.74%
Current month+0.24%
1 month+15.64%
3 months+26.98%
6 months+38.14%
Current year+27.75%
1 week 380.22
Extreme 380.225
394.29
1 month 325.31
Extreme 325.31
396.23
Current year 236.73
Extreme 236.73
396.23
1 year 236.73
Extreme 236.73
396.23
3 years 211.43
Extreme 211.43
396.23
5 years 211.43
Extreme 211.43
822.09
10 years 148.81
Extreme 148.81
832.7
Manager TitleAgeSince
Chief Executive Officer 76 2002-12-31
President 61 2024-09-08
Director of Finance/CFO 55 2024-04-14
Director TitleAgeSince
Chairman 76 2011-12-31
Director/Board Member 73 2017-04-24
Director/Board Member 79 2017-04-24
Date Insider Type Main position Quantity % Market Cap. Importance
7/25/26 Exercice

Executive/Senior Manager

581 0.0027%
5/11/26 Sell

Executive/Senior Manager

-550 0.0025%
4/24/26 Exercice

General Counsel

449 0.0020%
Change 5-day change 1-year change 3-year change Capi.($)
-0.24%-0.74%+34.37%+1.26% 10.27B
-1.73%-2.84%-17.98%+7.47% 191B
+0.54%+2.76%+0.22%+15.28% 118B
+0.07%+4.80%+14.06%+94.74% 64.19B
+0.16%-2.02%+26.41%+50.66% 51.49B
+0.04%-0.43%-1.20%-31.35% 51.08B
-0.11%+0.38%+13.57%-10.66% 33.85B
+1.31%+5.95% - - 31.85B
-0.37%-1.35%+37.14%-15.42% 24.11B
-0.06%-4.06%-7.43%+11.58% 22.96B
Average -0.05%-0.82%+11.02%+13.73% 59.89B
Weighted average by Cap. -0.38%-1.92%+0.58%+17.40%

Financials

2026 *2027 *
Net sales 2.57B 2.21B 2.08B 1.9B 3.55B 243B 3.58B 24.58B 9.57B 124B 9.66B 9.45B 400B 2.63B 2.27B 2.13B 1.95B 3.63B 249B 3.66B 25.15B 9.8B 127B 9.89B 9.67B 410B
Net income 225M 194M 182M 166M 310M 21.27B 313M 2.15B 837M 10.87B 845M 826M 35.01B 230M 198M 186M 170M 317M 21.74B 320M 2.2B 856M 11.11B 864M 845M 35.78B
Net Debt -749M -644M -605M -553M -1.03B -70.81B -1.04B -7.15B -2.79B -36.18B -2.81B -2.75B -117B -965M -831M -779M -713M -1.33B -91.26B -1.34B -9.22B -3.59B -46.64B -3.63B -3.55B -150B
Logo Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Employees
7,450
Date Price Change Volume
26-09-03 $387.06 -0.37% 68,411
26-09-02 $388.51 +1.98% 285,333
26-09-01 $380.96 -1.34% 256,110
26-08-31 $386.12 -0.41% 301,423
26-08-28 $387.70 -0.57% 206,972
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
388.51USD
Average target price
329.00USD
Spread / Average Target
-15.32%

Quarterly revenue - Rate of surprise